Thursday, August 21, 2014

Shifting sand!

Until we define clear biomarkers, Lupus and related autoimmune diseases will remain shifting sands, and experts don't help either, just read the statement pertaining to how to categorize:

"Several instruments have been developed for this purpose, including the British Isles Lupus Assessment Group (BILAG) index,[13] the European Consensus Lupus Activity Measurement (ECLAM),[14] and the SLE Disease Activity Index (SLEDAI).[15]" (MEDSCAPE)

how to compare the outcomes is also subsequently in flux
genetic biomarkers are still in the works!

Post a Comment